These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9228216)

  • 1. Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation.
    Reichrath J; Perez A; Müller SM; Chen TC; Kerber A; Bahmer FA; Holick MF
    Acta Derm Venereol; 1997 Jul; 77(4):268-72. PubMed ID: 9228216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin.
    Milde P; Hauser U; Simon T; Mall G; Ernst V; Haussler MR; Frosch P; Rauterberg EW
    J Invest Dermatol; 1991 Aug; 97(2):230-9. PubMed ID: 1649228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of proliferation of human epidermal keratinocytes by 1,25-dihydroxyvitamin D3. Analysis of its effect on psoriatic lesion and of its mechanism using human keratinocytes in culture.
    Kitano Y; Ikeda N; Okano M
    Eur J Clin Invest; 1991 Feb; 21(1):53-8. PubMed ID: 1907555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infilitration in psoriatic plaques by topical calcitriol.
    Lu I; Gilleaudeau P; McLane JA; Heftler N; Kamber M; Gottlieb S; Krueger JG; Gottlieb AB
    J Cutan Pathol; 1996 Oct; 23(5):419-30. PubMed ID: 8915850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
    Chen TC; Holick MF
    Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of integrin subunits and CD44 isoforms in psoriatic skin and effects of topical calcitriol application.
    Reichrath J; Horf R; Chen TC; Müller SM; Sanan D; Holick MF
    J Cutan Pathol; 1997 Sep; 24(8):499-506. PubMed ID: 9331896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: a cell biological study.
    Gerritsen MJ; Rulo HF; Van Vlijmen-Willems I; Van Erp PE; van de Kerkhof PC
    Br J Dermatol; 1993 Jun; 128(6):666-73. PubMed ID: 8101716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
    Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
    Abe J; Kondo S; Nishii Y; Kuroki T
    J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
    Takahashi H; Ibe M; Kinouchi M; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
    J Dermatol Sci; 2003 Feb; 31(1):21-8. PubMed ID: 12615360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
    Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
    J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D3-induced growth inhibition without affecting 1,25-dihydroxyvitamin D3-stimulated differentiation of primary mouse epidermal keratinocytes.
    Bollag WB; Zhong X; Josephson S
    BMC Pharmacol; 2004 Jul; 4():13. PubMed ID: 15279680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of psoriasis to a new topical retinoid, AGN 190168.
    Esgleyes-Ribot T; Chandraratna RA; Lew-Kaya DA; Sefton J; Duvic M
    J Am Acad Dermatol; 1994 Apr; 30(4):581-90. PubMed ID: 7512583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
    Durakovic C; Ray S; Holick MF
    Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
    Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
    Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium.
    Su MJ; Bikle DD; Mancianti ML; Pillai S
    J Biol Chem; 1994 May; 269(20):14723-9. PubMed ID: 7910167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
    Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
    Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.